Transitioning from population to individualized preventive cardiology

Clicks: 262
ID: 6823
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #124 of 242 articles by views in research reports in clinical cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 242 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Transitioning from population to individualized preventive cardiology Pamela B Morris,1 Richard F Wright2 1Seinsheimer Cardiovascular Health Program and Women’s Heart Care, Medical University of South Carolina, Charleston, SC, USA; 2Heart Failure Center, Pacific Heart Institute, Santa Monica, CA, USA Abstract: There is an ongoing discussion about whether treatment strategies developed from population based studies lead to inappropriate care of individual patients. This article proposes that despite management of lipid-lowering therapy to established low-density lipoprotein cholesterol (LDL-C) goals, significant residual risk for cardiovascular events remains in patients with established cardiovascular disease, diabetes, and metabolic syndrome (ie, central obesity, raised triglyceride levels and/or reduced high-density lipoprotein cholesterol levels). In these patients, LDL-C is often an inaccurate predictor of risk because the cholesterol content within the low-density lipoprotein particle (LDL-P) can be highly variable and thus LDL-C often inaccurately expresses an individual's likelihood of an atherosclerotic event. The LDL-P number has been found to be a better discriminator of cardiovascular risk than LDL-C in individual patients in several large epidemiologic studies that use sub-group analyses, including the Framingham Offspring Study and the Multi-Ethnic Study of Atherosclerosis. In contrast, epidemiology studies that utilize population statistics focusing on the role of lipids for initial risk assessment in entire populations do not separately evaluate these higher risk patients. The measurement of LDL-P in patients with cardiometabolic risk allows treatment of individuals through the optimization of lipid-lowering therapy to personalized goals, which would be expected to reduce that individual's risk of subsequent atherosclerotic events. Keywords: cardiovascular disease, individualized medicine, low-density lipoprotein particles, low-density lipoprotein cholesterol
Reference Key
pamela2013transitioningresearch Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pamela B Morris;Richard F Wright and
Journal research reports in clinical cardiology
Year 2013
DOI
10.2147/RRCC.S42829
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.